DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 128 participants.

Also called NCT06657833

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 128 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06657833
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands, Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06657833. Randomized; no masking; primary purpose treatment. Start 2024-12-17 (actual); primary completion 2027-10-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.
Acronym
DEBSCAN-IVL
Intervention (Device)
Percutaneous coronary intervention of a calcified nodule with intravascular lithotripsy followed by drug eluting balloon
Intervention (Device)
Percutaneous coronary intervention of a calcified nodule with intravascular lithotripsy followed by drug eluting stent
Lead sponsor
Fundación EPIC (class: other)

Record details

Record id
cardio:ct-nct06657833
Content hash
8dca378423c8c0cf03536bfb87eef34e755a5abec1827eb06c05e191038ee098